<DOC>
	<DOC>NCT02030548</DOC>
	<brief_summary>The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)</brief_summary>
	<brief_title>Bleeding in Patients Undergoing CABG During Dual Antiplatelet Therapy</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>consecutive patients undergoing acute CABG with or without valve replacement within 48 hours after last intake of dual antiplatelet therapy concomitant oral anticoagulants dialysis surgery employing hypothermic cardiac arrest</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>CABG</keyword>
	<keyword>dual antiplatelet therapy</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>prasugrel</keyword>
	<keyword>ticagrelor</keyword>
</DOC>